Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter P Liu

Showing results (181-190 of 191) with videos related to

Pageof 20
Sort By:
The Canadian Journal of Cardiology|April 5, 2011
Identification and management of cardiometabolic risk in Canada: a position paper by the cardiometabolic risk working group (executive summary), Lawrence A Leiter, David H Fitchett, et al.
Science Translational Medicine|December 15, 2021
A small molecule targeting ALOX12-ACC1 ameliorates nonalcoholic steatohepatitis in mice and macaquesXiao-Jing Zhang, Yan-Xiao Ji, Xu Cheng, et al.
Science Translational Medicine|December 15, 2021
Multiple omics study identifies an interspecies conserved driver for nonalcoholic steatohepatitisXiao-Jing Zhang, Zhi-Gang She, Junyong Wang, et al.
Cell Metabolism|September 18, 2021
Pharmacological inhibition of arachidonate 12-lipoxygenase ameliorates myocardial ischemia-reperfusion injury in multiple speciesXiao-Jing Zhang, Xiaolan Liu, Manli Hu, et al.
Hypertension (Dallas, Tex. : 1979)|July 17, 2020
Redefining Cardiac Biomarkers in Predicting Mortality of Inpatients With COVID-19Juan-Juan Qin, Xu Cheng, Feng Zhou, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 7, 2022
Canadian Cardiovascular Harmonized National Guideline Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2022 updateRahul Jain, James A Stone, Gina Agarwal, et al.
Circulation Research|April 18, 2020
Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19Peng Zhang, Lihua Zhu, Jingjing Cai, et al.
Nature Metabolism|December 8, 2025
Inhibition of IRAK4 by microbial trimethylamine blunts metabolic inflammation and ameliorates glycemic controlJulien Chilloux, Francois Brial, Amandine Everard, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 9, 2023
Rahul Jain, James A Stone, Gina Agarwal, et al.
Cell Metabolism|June 28, 2020
In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19Xiao-Jing Zhang, Juan-Juan Qin, Xu Cheng, et al.
Pageof 20

Showing results (181-190 of 191) with videos related to

Sort By:
Pageof 20
The Canadian Journal of Cardiology|April 5, 2011
Identification and management of cardiometabolic risk in Canada: a position paper by the cardiometabolic risk working group (executive summary), Lawrence A Leiter, David H Fitchett, et al.
Science Translational Medicine|December 15, 2021
A small molecule targeting ALOX12-ACC1 ameliorates nonalcoholic steatohepatitis in mice and macaquesXiao-Jing Zhang, Yan-Xiao Ji, Xu Cheng, et al.
Science Translational Medicine|December 15, 2021
Multiple omics study identifies an interspecies conserved driver for nonalcoholic steatohepatitisXiao-Jing Zhang, Zhi-Gang She, Junyong Wang, et al.
Cell Metabolism|September 18, 2021
Pharmacological inhibition of arachidonate 12-lipoxygenase ameliorates myocardial ischemia-reperfusion injury in multiple speciesXiao-Jing Zhang, Xiaolan Liu, Manli Hu, et al.
Hypertension (Dallas, Tex. : 1979)|July 17, 2020
Redefining Cardiac Biomarkers in Predicting Mortality of Inpatients With COVID-19Juan-Juan Qin, Xu Cheng, Feng Zhou, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 7, 2022
Canadian Cardiovascular Harmonized National Guideline Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2022 updateRahul Jain, James A Stone, Gina Agarwal, et al.
Circulation Research|April 18, 2020
Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19Peng Zhang, Lihua Zhu, Jingjing Cai, et al.
Nature Metabolism|December 8, 2025
Inhibition of IRAK4 by microbial trimethylamine blunts metabolic inflammation and ameliorates glycemic controlJulien Chilloux, Francois Brial, Amandine Everard, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 9, 2023
Rahul Jain, James A Stone, Gina Agarwal, et al.
Cell Metabolism|June 28, 2020
In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19Xiao-Jing Zhang, Juan-Juan Qin, Xu Cheng, et al.
Pageof 20